The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities.

about

The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities.

Item

http://www.wikidata.org/entity/Q48000346

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The ubiquitin-proteasome pathw ...... and therapeutic opportunities.

@en

The ubiquitin-proteasome pathw ...... and therapeutic opportunities.

@nl

type

Item

label

The ubiquitin-proteasome pathw ...... and therapeutic opportunities.

@en

The ubiquitin-proteasome pathw ...... and therapeutic opportunities.

@nl

prefLabel

The ubiquitin-proteasome pathw ...... and therapeutic opportunities.

@en

The ubiquitin-proteasome pathw ...... and therapeutic opportunities.

@nl

P1476

The ubiquitin-proteasome pathw ...... and therapeutic opportunities.

@en

P2093

Christa Manton

http://www.w3.org/2001/XMLSchema#string

Claudia P Miller

http://www.w3.org/2001/XMLSchema#string

Joya Chandra

http://www.w3.org/2001/XMLSchema#string

Soumen Khatua

http://www.w3.org/2001/XMLSchema#string

Vidya Gopalakrishnan

http://www.w3.org/2001/XMLSchema#string

Wafik Zaky

http://www.w3.org/2001/XMLSchema#string

P2860

Pediatric medulloblastoma - update on molecular classification driving targeted therapies

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1)

Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase

ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor

Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells

Mdm2 promotes the rapid degradation of p53

FBXL2- and PTPL1-mediated degradation of p110-free p85β regulatory subunit controls the PI(3)K signalling cascade

26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

mTOR: from growth signal integration to cancer, diabetes and ageing

P2888

s10555-017-9700-2

P304

617-633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10555-017-9700-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29071526

http://www.w3.org/2001/XMLSchema#string